IDiyas

For the Inventor, By the Inventor

Takarazuka, Japan

Eiji Higashide

USPTO Granted Patents = 17

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 207(Granted Patents)


Location History:

  • Hyogo, JP (1982)
  • Takarazuka, JP (1979 - 1986)

Company Filing History:

goldMedal17 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1979-1986

Loading Chart...
17 patents (USPTO):Explore Patents
1. 4623733 - Antimicrobial peptide (1986-11-18),
2. 4575489 - Streptomyces albulus subsp. ochragerus subsp. nov. culture for making (1986-03-11),
3. 4465844 - Alanyl-2-(5-hydroxy-2-oxo-pyrrolidin-3-yl)glycine (1984-08-14),
4. 4436918 - Method for production of peptide, and its intermediate (1984-03-13),
5. 4373028 - Culture of Nocardia ATCC 31309 (1983-02-08),
6. 4360462 - Process for preparing maytansinol (1982-11-23),
7. 4320200 - Antibiotic (1982-03-16),
8. 4315989 - Biologically pure culture of the microorganism Nocardia ATCC31280 (1982-02-16),
9. 4298600 - Antibiotic C-14482 A.sub.1 and method for producing same (1981-11-03),
10. 4292309 - Antibiotics C-14482 B.sub.1, B.sub.2 and B.sub.3 (1981-09-29),
11. 4245047 - Antibiotics produced from the microorganism nocardia (1981-01-13),
12. 4229533 - Method for producing antibiotic C-15003 P-4 (1980-10-21),
13. 4228239 - Method for producing antibiotic C-15003 P-3 (1980-10-14),
14. 4225494 - Maytansinol esters (1980-09-30),
15. 4187292 - Antibiotics produced from the microorganism nocardice (1980-02-05),

Title: Eiji Higashide: A Pioneer in Antimicrobial Research

Introduction

Eiji Higashide is a prominent inventor based in Takarazuka, Japan. With a remarkable portfolio comprising 17 patents, he has made significant contributions to the field of antimicrobial research through his innovative work. His groundbreaking patents showcase his dedication to improving public health and safety by leveraging natural compounds derived from microorganisms.

Latest Patents

Eiji Higashide's latest inventions revolve around a novel antimicrobial peptide known as B-52653. This unique peptide is produced by cultivating a specific microorganism from the genus Streptomyces. The innovative process involves the microorganism elaborating and accumulating B-52653 in the culture medium, allowing for efficient recovery. The compound has shown potential as a powerful germicide and disinfectant, with additional possibilities suggesting its utility as an antifibrotic agent.

Career Highlights

Eiji Higashide's career is marked by his association with Takeda Chemical Industries, Inc., where he has dedicated his expertise to advancing antimicrobial solutions. Throughout his tenure, he has demonstrated a relentless pursuit of innovation, resulting in a series of impactful patents that reflect his commitment to scientific advancement.

Collaborations

In his quest for excellence, Eiji collaborates with esteemed colleagues, including Mitsuko Asai and Seiichi Tanida. Together, they form a formidable team dedicated to exploring the vast potential of microbial biotechnology and furthering our understanding of antimicrobial agents.

Conclusion

Eiji Higashide stands out as a visionary inventor whose work on antimicrobial peptides is set to make a lasting impact. Through his innovative patents and collaborations at Takeda Chemical Industries, Inc., he continues to pave the way for advancements in germicidal and antifibrotic solutions. His contributions not only enhance scientific knowledge but also hold promise for improving public health on a global scale.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…